<span style="white-space: normal;">Mechanism and prevention for complications of laparoscopic cholecystectomy</span>

[1]	Huang Ling, Ning HuiMing, Xu YanHua, Tang Qun, Ou Qiang. Clinical effect of entecavir combined with thymosin in treatment of HBe Ag-positive hepatitis B patients[J]. Journal of Clinical Hepatology, 2016, 32(11): 2070-2074. doi: 10.3969/j.issn.1001-5256.2016.11.011
[2]	Sun JianMin. Efficacy of low-dose interferon α-1b combined with ribavirin and thymosin α1 versus standard treatment for chronic hepatitis C: a comparative study [J]. Journal of Clinical Hepatology, 2015, 31(1): 107-109. doi: 10.3969/j.issn.1001-5256.2015.01.023
[3]	Zhao XiaoLing, Zhang YongGang. Clinical efficacy of ribavirin combined with different doses of interferon α- 2b in patients with chronic hepatitis C genotypes 2 and 3[J]. Journal of Clinical Hepatology, 2013, 29(10): 780-783. doi: 10.3969/j.issn.1001-5256.2013.10.014
[4]	Zhu Yan, Mao Qing, Zhang ZhangJiang, Sun Wei, Hu YaJun, Tan ChaoXia, Wang XiaoHong. Retreatment with pegylated interferon alpha-2a/2b and ribavirin in previous relapsers with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2011, 27(1): 86-88.
[5]	Jin Rui, Zhang ShiBin, Bian XinQu, Lu ChengZhen, Liu ZhongSheng, Guo XinHui. Clinical study of IFNα-2b alone or in combination with lamivudine for HBeAg positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(6): 617-619.
[6]	Zhang WenJie, Li ChaoXia, Tian ShuJu, Mao WeiWu, Gong YanXuan, Qu Yan. Generation of neutralizing anti-interferon antibodies and its influence on the interferon-alpha (IFN-alpha) treatment for chronic hepatitis C[J]. Journal of Clinical Hepatology, 2010, 26(1): 27-30.
[8]	Li Jun, Chen XinYue, Zhao Hong, Yu YanYan, Si ChongWen, Han ZhongHou, Zhang WenJin, Chen YuPing, Chen Yong, Wang GuiQiang, Yu Min, Gong WeiBo, Xu JingHang, Wang Jun, Lin XiaoHong, Li XueYing. The relationship of hepatitis B virus genotypes and efficacy of lamivudine and interferon alpha 2b in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(3): 169-171.
[9]	Guo HaiYan, Chen Ming, Wang LiPing, Ge GuoHong, Zhang YanChao. Recent thymic output function in patients with chronic hepatitis C by real time fluorescence quantitative PCR analysis[J]. Journal of Clinical Hepatology, 2007, 23(6): 432-433.
[10]	Xiao Yang, Hu CaoHan, Zhou YueJin, Xie QingRong, Zhu BingXing, Hu Xia, Wang KaiJian, Zhang WenJing. Effect of hepatitis B virus genotypes on response to interferon α2b in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2006, 22(2): 105-106.
[11]	Pei Bin, Chen ZhangRong, Huang WenQi, Xie JinZhen. The change of Th1/Th2 cytokines expression in treatment of chronic hepatitis C with IFN-α and ribavirin[J]. Journal of Clinical Hepatology, 2006, 22(3): 188-190.
[13]	Jiao Jian, Wang JiangBin. Study on the response to combined α-IFN, ribavilin and thymosin α1 for different types HCV infection and HCV-HBV coinfection[J]. Journal of Clinical Hepatology, 2004, 20(5): 273-274.
[18]	Wang LanYing, Wang ZhiBin, Xu DaoZhen. HBsAg-iRNA and Ara-AMP combine with thymus peptide therapy of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2000, 16(2): 110-111.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2384) PDF downloads(620)

Mechanism and prevention for complications of laparoscopic cholecystectomy

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Mechanism and prevention for complications of laparoscopic cholecystectomy

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content